Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Illumigyn

Request full access

Revolutionizes women’s health and take gynecology into the 21st Century

Neve Ilan, IsraelFounded 2012Health Tech & Medtech

About Illumigyn

Illumigyn, established in 2012 by Ran Poliakine and Lior Greenstein, is a medical technology company focused on advancing gynecological examinations. The firm developed the Gynoscope system, a novel device designed to digitize and enhance the standard colposcopy procedure used for cervical cancer screening. The development of this technology was influenced by the founders' backgrounds; Poliakine is a serial entrepreneur with a history of founding technology companies, while Greenstein brings experience from the medical device industry. Their combined expertise aimed to address the limitations of traditional gynecological imaging.

The company's core offering, the Gynoscope, is a compact, high-resolution imaging system that attaches to a standard speculum. It captures and illuminates the cervix, vagina, and vulva, allowing for detailed examination and documentation. A key feature of the system is its ability to upload captured images and data to a secure cloud platform. This enables physicians to remotely access patient information, consult with specialists, and utilize AI-based algorithms for diagnostic support. The system is designed to be operated by any trained healthcare professional, not just gynecologists, with the goal of expanding access to quality screening in various healthcare settings.

Illumigyn operates on a business-to-business model, supplying its Gynoscope systems to hospitals, clinics, and healthcare providers. Its revenue is likely generated from the sale of the devices and potentially through a subscription model for its cloud platform and associated services. The company targets the global women's health market, with a particular emphasis on improving early detection rates for cervical cancer and other pathologies. By providing a tool for more accessible and documented examinations, Illumigyn aims to standardize the quality of care and create a comprehensive database for future research and analysis. The company has secured CE marking for its product, allowing for its commercialization within the European market, and has established distribution agreements in various regions, including the Gulf countries, India, and Africa.

Source: Dealroom company data

At a glance

Status
Operational
Employees
17
Open positions
None listed
Dealroom signal
67.0/100
Industry
Health
Sub-industry
Medical Devices
Sector
Visualization, Oncology, Women's Health, Femtech, Tech for Hospitals and Clinics, Clinical Decision Support
Technology
Artificial Intelligence, Big Data, Deep Tech, Computer Vision
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Nov 2021 $33M $132M Yozma Group · Ubicom —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Illumigyn website traffic

Latest recorded traffic for Illumigyn is 300 monthly website visits, up 650% over the last three months. Illumigyn's team declined 15% over the past year.

Latest monthly visits300 3-month web change+650% 1-year team growth-15%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Illumigyn in the Neve Ilan ecosystem

Live from Dealroom

The Illumigyn office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

  • Yozma Group
  • Ubicom

Other known investors1 additional known investor

  • VOLA Investment
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Illumigyn’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.